Rifadin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin.
Product ID | 0068-0508_10a42985-61e0-4145-92ee-703871e7312a |
NDC | 0068-0508 |
Product Type | Human Prescription Drug |
Proprietary Name | Rifadin |
Generic Name | Rifampin |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1971-05-21 |
Marketing End Date | 2020-10-31 |
Marketing Category | NDA / NDA |
Application Number | NDA050420 |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | RIFAMPIN |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Rifamycin Antibacterial [EPC],Rifamycins [CS] |
NDC Exclude Flag | N |
Marketing Start Date | 1971-05-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050420 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1971-05-21 |
Marketing End Date | 2017-07-31 |
Marketing Category | NDA |
Application Number | NDA050420 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1971-05-21 |
Marketing Category | NDA |
Application Number | NDA050420 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1971-05-21 |
Marketing End Date | 2013-04-15 |
Ingredient | Strength |
---|---|
RIFAMPIN | 300 mg/1 |
SPL SET ID: | 036ab68e-5085-4edc-bd83-784b43d64eab |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0068-0508 | Rifadin | rifampin |
0068-0510 | Rifadin | rifampin |
0068-0597 | Rifadin IV | rifampin |
0068-0599 | Rifadin IV NOVAPLUS | rifampin |
0143-9230 | Rifampin | Rifampin |
0185-0799 | Rifampin | Rifampin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RIFADIN 72314539 0879813 Live/Registered |
DOW CHEMICAL COMPANY, THE 1968-12-16 |